These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6209973

  • 21. Receptor-mediated internalization of tuftsin by human polymorphonuclear leukocytes.
    Amoscato AA, Davies PJ, Babcock GF, Nishioka K.
    J Reticuloendothel Soc; 1983 Jul; 34(1):53-67. PubMed ID: 6308252
    [Abstract] [Full Text] [Related]

  • 22. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA.
    Exp Cell Biol; 1978 Jul; 46(1-2):114-26. PubMed ID: 579629
    [Abstract] [Full Text] [Related]

  • 23. Stability of sterile saline solutions of synthetic tuftsin, a naturally occurring immunomodulating peptide.
    Nishioka K, Dessens SE, Rodriguez T.
    Pept Res; 1991 Jul; 4(4):230-3. PubMed ID: 1823602
    [Abstract] [Full Text] [Related]

  • 24. Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.
    Gupta CM, Haq W.
    Methods Enzymol; 2005 Jul; 391():291-304. PubMed ID: 15721387
    [Abstract] [Full Text] [Related]

  • 25. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH, Babcock GF, Nishioka K.
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [Abstract] [Full Text] [Related]

  • 26. The evidence on the possible interleukin-1 alpha tuftsin competition.
    Siemion IZ, Słoń J, Spiegel K, Wieczorek Z.
    Arch Immunol Ther Exp (Warsz); 1991 Mar; 39(5-6):605-11. PubMed ID: 1841557
    [Abstract] [Full Text] [Related]

  • 27. Effect of tuftsin on human Kupffer cell.
    Kubo S, Roh MS, Oyedeji C, Romsdahl MM, Nishioka K.
    Hepatogastroenterology; 1998 Mar; 45(24):2270-4. PubMed ID: 9951909
    [Abstract] [Full Text] [Related]

  • 28. The biological activity of new tuftsin derivatives--induction of phagocytosis.
    Wardowska A, Dzierzbicka K, Trzonkowski P, Myśliwski A.
    Acta Pol Pharm; 2006 Mar; 63(5):378-81. PubMed ID: 17357588
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R, Biondi L, Cavaggion F, Filira F, Gobbo M, Dagan S, Fridkin M.
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [Abstract] [Full Text] [Related]

  • 30. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E, Słoń JJ, Klin M, Madej A, Siemion IZ, Herman ZS.
    Pol J Pharmacol; 1993 Feb; 45(3):269-79. PubMed ID: 8220660
    [Abstract] [Full Text] [Related]

  • 31. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
    Polevshchikov AV, Nazarov PG.
    Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
    [Abstract] [Full Text] [Related]

  • 32. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M.
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates.
    Xu Y, Zhu J, Xiang K, Li Y, Sun R, Ma J, Sun H, Liu Y.
    Biomaterials; 2011 Dec; 32(36):9940-9. PubMed ID: 21937103
    [Abstract] [Full Text] [Related]

  • 34. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
    Fridkin M, Gottlieb P.
    Mol Cell Biochem; 1981 Dec 04; 41():73-97. PubMed ID: 7035869
    [Abstract] [Full Text] [Related]

  • 35. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
    Dagan S, Tzehoval E, Fridkin M, Feldman M.
    J Biol Response Mod; 1987 Dec 04; 6(6):625-36. PubMed ID: 3502474
    [Abstract] [Full Text] [Related]

  • 36. [The effect of the calf spleen and calf thymus extracts, thymopentin and tuftsin, on the phagocytosis activity of neutrophilic granulocytes].
    Krasowski H, Stehle P, Fürst P, Kraus W.
    Arzneimittelforschung; 1992 Feb 04; 42(2):147-51. PubMed ID: 1610426
    [Abstract] [Full Text] [Related]

  • 37. A biochemical study of the phagocytic activities of tuftsin and its analogues.
    Hisatsune K, Nozaki S, Ishikawa T, Hayashi M, Nogaki K, Ogawa H.
    Ann N Y Acad Sci; 1983 Feb 04; 419():205-13. PubMed ID: 6585169
    [Abstract] [Full Text] [Related]

  • 38. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
    Stabinsky Y, Bar-Shavit Z, Fridkin M, Goldman R.
    Mol Cell Biochem; 1980 Apr 18; 30(2):71-7. PubMed ID: 6247642
    [Abstract] [Full Text] [Related]

  • 39. Specific translocation of tuftsin (Thr-Lys-Pro-Arg), a natural immunomodulating peptide, into the nuclei of human monocytes.
    Wagle JR, Ansevin AT, Dessens SE, Nishioka K.
    Biochem Biophys Res Commun; 1989 Mar 31; 159(3):1147-53. PubMed ID: 2494998
    [Abstract] [Full Text] [Related]

  • 40. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
    Najjar VA.
    Klin Wochenschr; 1979 Aug 01; 57(15):751-6. PubMed ID: 385971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.